J&J: Sirturo significantly improved treatment outcomes in patients with rifampicin-resistant tuberculosis.
83% of participants on an oral Sirturo-containing regimen achieved a favorable outcome compared to 71% of patients on the control ...
Tag: tb
#VisualAbstract: Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis
1. In this randomized control trial, an eight-week bedaquiline-linezolid regimen was noninferior to standard 24-week treatment for tuberculosis. 2. The ...
#VisualAbstract: All-oral regimen with delamanid, linezolid, levofloxacin, and pyrazinamide is effective for fluoroquinolone-sensitive multidrug-resistant tuberculosis
1. At 24 months, treatment success rate was numerically greater in the shorter-regimen group versus conventional therapy, satisfying the noninferiority ...
All-oral regimen with delamanid, linezolid, levofloxacin, and pyrazinamide is effective for fluoroquinolone-sensitive multidrug-resistant tuberculosis
1. At 24 months, treatment success rate was numerically greater in the shorter-regimen group versus conventional therapy, satisfying the noninferiority ...
#VisualAbstract: Non-severe tuberculosis in children can be treated with a shorter 4-month regimen instead of 6-month regimen
1. For children with non-severe tuberculosis, 4 months of antituberculosis treatments was non-inferior to 6 months of antituberculosis treatments. 2. ...
#VisualAbstract: Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis
1. Rifapentine-moxifloxacin treatment was shown to be non-inferior compared to standard therapy for tuberculosis. 2. Rifapentine without moxifloxacin treatment was ...
#VisualAbstract: Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease
1. After 3 years of weekly vitamin D supplementation, the proportion of children who tested positive on interferon-gamma release assays ...
#VisualAbstract: Treating latent tuberculosis infection with four months of rifampin versus nine months of isoniazid
1. When compared to 9 months of isoniazid, 4 months of rifampin was a non-inferior alternative treatment of latent tuberculosis ...